BridgeBio Pharma
Price & Volume
Stats
See more52W Range | $21.62-$39.47 |
Market Cap | $6.4B |
Shares Short | 21M |
Financials
See moreRevenue (12 Mos) | $221.9M |
Revenue Growth (YoY) | 237.1% |
Gross Profit (12 Mos) | $218M |
Diluted EPS | -$2.88 |
News
See moreYahoo Finance • 7 days ago
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 18 days ago
Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM
Yahoo Finance • 20 days ago
Why BridgeBio Pharma (BBIO) Is Among the Best Mid Cap Biotech Stocks to Buy
About
CEO | Dr. Neil Kumar Ph.D. |
CFO | Dr. Thomas Trimarchi Ph.D. |
Address | 3160 Porter Drive, Palo Alto, CA, United States, 94304 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 725 |
